| Condition | Key Finding | Association | Board Exam Tip |
|---|---|---|---|
| Hereditary Spherocytosis | Red cells lacking central pallor; Elevated MCHC | Spectrin, Ankyrin, Band 3 defects | Think osmotic fragility test and pigment gallstones. |
| Paroxysmal Nocturnal Hemoglobinuria (PNH) | Thrombosis, Hemolysis, Low {CD}55/{CD}59 | {PIGA} gene mutation; Complement deficiency | Treatment involves C5 blockade ({Eculizumab}). |
| Sickle Cell Disease (SCD) | Vaso-occlusion; Dactylitis in infants | -globin chain Glu -> Val substitution | Remember the severity order: {HbSS} is worst. |
| Coombs Test | Direct vs. Indirect testing | Autoimmune Hemolytic Anemia (AIHA) | Direct = on RBCs; Indirect = in serum. |
| Topic | Key Point | Context | Exam Relevance |
|---|---|---|---|
| Hereditary Spherocytosis | Membrane protein defects ({Spectrin}, {Ankyrin}) cause loss of membrane surface area. | Leads to spherocytes and increased MCHC; susceptible to osmotic lysis. | High yield for physical exam/blood smear questions. |
| Direct Coombs Test | Detects antibodies bound to the RBC membrane. | Used in Autoimmune Hemolytic Anemia (AIHA). Positive result confirms antibody binding. | Crucial distinction from Indirect test. |
| Intravascular Hemolysis | Occurs within the circulation; involves complement activation. | Characterized by low {haptoglobin} and schistocytes ({DIC}, PNH, {PTG}). | Low haptoglobin is a hallmark of intravascular destruction. |
| PNH Pathophysiology | Deficiency of GPI-anchored proteins ({CD}55, {CD}59) due to {PIGA} mutation. | Allows uncontrolled complement attack on RBCs, leading to hemolysis and thrombosis. | Remember the treatment is C5 blockade (Eculizumab). |